NCT00943683 Montelukast in Pediatric Patients Aged 6 to 24 Months With Asthma--Safety Study (0476-176) Status COMPLETED Phase NA
NCT00943397 Extended Safety Study of Montelukast in Infants and Young Children With Chronic Asthma (0476-232) Status COMPLETED Phase PHASE3
NCT00941798 Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma Status COMPLETED Phase PHASE2
NCT00941577 Study Evaluating the Effects of AIR645 on Allergen-Induced Airway Responses in Subjects With Mild Atopic Asthma Status COMPLETED Phase PHASE2
NCT00940160 Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of QAX576 in Asthma Patients Status COMPLETED Phase PHASE1/PHASE2
NCT00939354 Asthma in the Elderly: The Role of Exhaled Nitric Oxide Measurements Status COMPLETED Phase N/A
NCT00939341 Study to Investigate Real Life Effectiveness of Symbicort Maintenance and Reliever Therapy in Asthma Patients Across Asia Status COMPLETED Phase PHASE4
NCT00937066 Cost-effectiveness Study of Symbicort as Maintenance and Reliever Therapy (SMART) Status COMPLETED Phase N/A
NCT00936793 Drug Interaction Study Between Inhaled Beclomethasone and Protease Inhibitors in Healthy Volunteers Status COMPLETED Phase PHASE1
NCT00936624 Dose Finding Trial to Assess the Efficacy and Safety of SOTB07 in Persistent Asthma Status COMPLETED Phase PHASE2
NCT00935077 A Collaborative Model to Improve Blood Pressure (BP) Control and Minimize Racial Disparities Status COMPLETED Phase PHASE3
NCT00930163 A Study of Lebrikizumab (MILR1444A) in Adult Patients With Asthma Who Are Inadequately Controlled on Inhaled Corticosteroids Status COMPLETED Phase PHASE2
NCT00928668 Efficacy (Bronchoprotection) and Safety of Orally Inhaled BI 1744 CL in Patients With Intermittent Asthma Status COMPLETED Phase PHASE2
NCT00927901 Efficacy, Safety, Tolerability, and Pharmacokinetics of Indacaterol Salts in Patients With Asthma Status COMPLETED Phase PHASE2
NCT00927758 Pilot Study to Examine the Post-Dose Changes in Exhaled Nitric Oxide (eNO) Following Treatment With Fluticasone Propionate (FP)/Salmeterol (SAL) Combination Product Advair Status COMPLETED Phase PHASE2
NCT00927329 Evaluation of a Nasal Allergen Challenge Procedure Using Dust Mite Extract Status WITHDRAWN Phase PHASE1